Published in Mol Pharmacol on September 13, 2010
The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels. Br J Pharmacol (2013) 1.88
Kainate receptor subunit diversity underlying response diversity in retinal off bipolar cells. J Physiol (2014) 1.13
Synaptic pathways that shape the excitatory drive in an OFF retinal ganglion cell. J Neurophysiol (2011) 0.98
Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors. J Med Chem (2011) 0.90
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics (2005) 34.83
The SWISS-MODEL Repository and associated resources. Nucleic Acids Res (2008) 11.61
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res (2002) 6.64
Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity. Neuron (2005) 2.65
Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. Neuron (1990) 2.30
Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature (1991) 2.25
Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology (2008) 1.70
Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. J Neurosci (2006) 1.70
Kainate receptor physiology. Curr Opin Pharmacol (2005) 1.53
Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit. Neuron (1992) 1.40
Glutamate receptor trafficking: endoplasmic reticulum quality control involves ligand binding and receptor function. J Neurosci (2005) 1.25
Molecular characterization of the human EAA5 (GluR7) receptor: a high-affinity kainate receptor with novel potential RNA editing sites. Receptors Channels (1994) 1.09
Identification of functional ionotropic glutamate receptor proteins in pancreatic beta-cells and in islets of Langerhans. FEBS Lett (1995) 1.09
Glutamate receptors and endoplasmic reticulum quality control: looking beneath the surface. Neuroscientist (2006) 1.08
Biochemical and immunocytochemical characterization of antipeptide antibodies to a cloned GluR1 glutamate receptor subunit: cellular and subcellular distribution in the rat forebrain. Neuroscience (1993) 1.04
Ligand binding is a critical requirement for plasma membrane expression of heteromeric kainate receptors. J Biol Chem (2004) 1.03
Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes. J Med Chem (1997) 1.03
Glutamate binding and conformational flexibility of ligand-binding domains are critical early determinants of efficient kainate receptor biogenesis. J Biol Chem (2009) 0.97
Antagonism of recombinant and native GluK3-containing kainate receptors. Neuropharmacology (2008) 0.97
ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function. Neuropharmacology (2008) 0.97
Assembly and cell surface expression of KA-2 subunit-containing kainate receptors. J Neurochem (2003) 0.94
Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists. Neuropharmacology (2010) 0.85
Assembly and intracellular distribution of kainate receptors is determined by RNA editing and subunit composition. J Neurochem (2010) 0.85
Functional expression and pharmacological characterization of the human EAA4 (GluR6) glutamate receptor: a kainate selective channel subunit. Receptors Channels (1994) 0.82
cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration. Receptors Channels (1995) 0.81
Synthesis and receptor binding affinity of new selective GluR5 ligands. Bioorg Med Chem (2001) 0.80
Ontogeny of kainate receptor gene expression in the developing rat midbrain and striatum. Brain Res Mol Brain Res (2002) 0.79
Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. J Neurosci (2006) 1.70
Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. Br J Pharmacol (2004) 1.45
The glutamate story. Br J Pharmacol (2006) 1.45
Dynamics of the S1S2 glutamate binding domain of GluR2 measured using 19F NMR spectroscopy. J Biol Chem (2007) 1.41
Metabotropic glutamate receptor-mediated long-term depression: molecular mechanisms. Pharmacol Rev (2009) 1.40
Number and density of AMPA receptors in individual synapses in the rat cerebellum as revealed by SDS-digested freeze-fracture replica labeling. J Neurosci (2007) 1.28
Mechanism of partial agonism at the GluR2 AMPA receptor: Measurements of lobe orientation in solution. Biochemistry (2008) 1.26
The NMDA receptor as a target for cognitive enhancement. Neuropharmacology (2012) 1.24
A novel family of negative and positive allosteric modulators of NMDA receptors. J Pharmacol Exp Ther (2010) 1.22
The different effects on recognition memory of perirhinal kainate and NMDA glutamate receptor antagonism: implications for underlying plasticity mechanisms. J Neurosci (2006) 1.20
Input-specific intrasynaptic arrangements of ionotropic glutamate receptors and their impact on postsynaptic responses. J Neurosci (2009) 1.15
Extrasynaptic NR2D-containing NMDARs are recruited to the synapse during LTP of NMDAR-EPSCs. J Neurosci (2008) 1.12
Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain. Biochemistry (2009) 1.12
Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. Neuropharmacology (2004) 1.11
Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. J Med Chem (2005) 1.11
Numbers, densities, and colocalization of AMPA- and NMDA-type glutamate receptors at individual synapses in the superficial spinal dorsal horn of rats. J Neurosci (2008) 1.08
Small conductance calcium-activated potassium channels: from structure to function. Prog Neurobiol (2010) 1.06
NMDA receptor-dependent long-term potentiation comprises a family of temporally overlapping forms of synaptic plasticity that are induced by different patterns of stimulation. Philos Trans R Soc Lond B Biol Sci (2013) 1.05
N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. J Pharmacol Exp Ther (2009) 1.05
TBK1 kinase addiction in lung cancer cells is mediated via autophagy of Tax1bp1/Ndp52 and non-canonical NF-κB signalling. PLoS One (2012) 1.04
Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket. J Pharmacol Exp Ther (2005) 1.03
Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators. Neurochem Int (2012) 1.02
Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid. Neuropharmacology (2011) 0.99
Allosteric block of KCa2 channels by apamin. J Biol Chem (2010) 0.99
LTP in hippocampal neurons is associated with a CaMKII-mediated increase in GluA1 surface expression. J Neurochem (2011) 0.98
ACET is a highly potent and specific kainate receptor antagonist: characterisation and effects on hippocampal mossy fibre function. Neuropharmacology (2008) 0.97
Antagonism of recombinant and native GluK3-containing kainate receptors. Neuropharmacology (2008) 0.97
Tyrosine dephosphorylation regulates AMPAR internalisation in mGluR-LTD. Mol Cell Neurosci (2008) 0.96
Different NMDA receptor subtypes mediate induction of long-term potentiation and two forms of short-term potentiation at CA1 synapses in rat hippocampus in vitro. J Physiol (2012) 0.95
Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. J Med Chem (2005) 0.95
Inhibition of kainate receptors reduces the frequency of hippocampal theta oscillations. J Neurosci (2007) 0.94
The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. Neuropharmacology (2005) 0.93
Molecular mechanism of myosin Va recruitment to dense core secretory granules. Traffic (2011) 0.92
Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses. J Neurochem (2009) 0.91
Piperazine-2,3-dicarboxylic acid derivatives as dual antagonists of NMDA and GluK1-containing kainate receptors. J Med Chem (2011) 0.90
Target- and input-dependent organization of AMPA and NMDA receptors in synaptic connections of the cochlear nucleus. J Comp Neurol (2014) 0.90
Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J Neurochem (2006) 0.89
Developmental regulation of G protein-gated inwardly-rectifying K+ (GIRK/Kir3) channel subunits in the brain. Eur J Neurosci (2011) 0.88
Developing oligodendrocytes express functional GABA(B) receptors that stimulate cell proliferation and migration. J Neurochem (2006) 0.88
Kainate receptors and mossy fiber LTP. Neurotoxicology (2005) 0.87
Antagonists reversibly reverse chemical LTD induced by group I, group II and group III metabotropic glutamate receptors. Neuropharmacology (2013) 0.86
Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists. J Med Chem (2006) 0.85
Assembly and intracellular distribution of kainate receptors is determined by RNA editing and subunit composition. J Neurochem (2010) 0.85
Structural requirements for novel willardiine derivatives acting as AMPA and kainate receptor antagonists. Br J Pharmacol (2003) 0.84
Activation of cyclic AMP-dependent protein kinase inhibits the desensitization and internalization of metabotropic glutamate receptors 1a and 1b. Mol Pharmacol (2004) 0.83
The novel antagonist 3-CBW discriminates between kainate receptors expressed on neonatal rat motoneurones and those on dorsal root C-fibres. Br J Pharmacol (2002) 0.83
MyRIP interaction with MyoVa on secretory granules is controlled by the cAMP-PKA pathway. Mol Biol Cell (2012) 0.83
Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-D-aspartate receptors. Neurochem Int (2012) 0.82
Differences in kainate receptor involvement in hippocampal mossy fibre long-term potentiation depending on slice orientation. Neurochem Int (2012) 0.82
Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo. Mol Neurodegener (2011) 0.82
Lateral entorhinal cortex lesions rearrange afferents, glutamate receptors, increase seizure latency and suppress seizure-induced c-fos expression in the hippocampus of adult rat. J Neurochem (2005) 0.81
Distinct cerebellar engrams in short-term and long-term motor learning. Proc Natl Acad Sci U S A (2013) 0.81
GLUK1 receptor antagonists and hippocampal mossy fiber function. Int Rev Neurobiol (2009) 0.80
mGluR5 is involved in dendrite differentiation and excitatory synaptic transmission in NTERA2 human embryonic carcinoma cell-derived neurons. Neuropharmacology (2007) 0.79
Repeated application of 4-aminopyridine provoke an increase in entorhinal cortex excitability and rearrange AMPA and kainate receptors. Neurotox Res (2015) 0.78
Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord. Br J Pharmacol (2003) 0.78
Mechanisms of bi-directional modulation of thalamocortical transmission in barrel cortex by presynaptic kainate receptors. Neuropharmacology (2010) 0.78
Isolation of human genomic DNA for genetic analysis from premature neonates: a comparison between newborn dried blood spots, whole blood and umbilical cord tissue. BMC Genet (2013) 0.78
Ca2+-calmodulin increases RyR2 open probability yet reduces ryanoid association with RyR2. Biophys J (2009) 0.77
Phenylglycine derivatives as antagonists of group III metabotropic glutamate receptors expressed on neonatal rat primary afferent terminals. Br J Pharmacol (2003) 0.77
Are Neto1 and APP auxiliary subunits of NMDA receptors? J Neurochem (2013) 0.77
Pre- and post-synaptic functions of kainate receptors at glutamate and GABA synapses in the rat entorhinal cortex. Hippocampus (2011) 0.77
Repeated 4-aminopyridine induced seizures diminish the efficacy of glutamatergic transmission in the neocortex. Exp Neurol (2009) 0.76
Metabotropic glutamate receptor mGlu2 is resistant to homologous agonist-induced desensitization but undergoes protein kinase C-mediated heterologous desensitization. Eur J Pharmacol (2010) 0.76
Calcium and NeuroD2 control the development of thalamocortical communication. Neuron (2006) 0.76
Characterisation of an mGlu8 receptor-selective agonist and antagonist in the lateral and medial perforant path inputs to the dentate gyrus. Neuropharmacology (2012) 0.76
Detection of three closely located single nucleotide polymorphisms in the EAAT2 promoter: comparison of single-strand conformational polymorphism (SSCP), pyrosequencing and Sanger sequencing. BMC Genet (2014) 0.75
The role of GLU K5-containing kainate receptors in entorhinal cortex gamma frequency oscillations. Neural Plast (2008) 0.75
Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery. J Med Chem (2014) 0.75
A soluble-polymer system for the asymmetric transfer hydrogenation of ketones. J Org Chem (2004) 0.75